CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$0.06
52W Range
$0.05 - $572.00
50D Avg
$2.92
200D Avg
$11.95
Market Cap
$72.92K
Avg Vol (3M)
$2.53M
Beta
0.32
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.